|
|
 |
| Primary Symbol & Exchange: |
| AZN - Ordinary Shares - London |
| Other Symbols & Exchanges: |
| AZN - ADR - New York Stock Exchange |
| ZEG - Common Stock - Frankfurt |
| AZN - Common Stock - Stockholm (Nasdaq OMX Group) |
| AZNCF - Dual Listed - Other-OTC |
|
|
| Industry: |
| Pharmaceutical |
|
|
|
|
|
|
|
| Mergers & Acquisitions: |
| AstraZeneca plc Mergers and Acquisitions
|
|
Thomson Financial Business Description:
| The Group's principal activity is discovering, developing, manufacturing and marketing prescription pharmaceuticals and biological products. The Group's operation focuses on six therapeutic areas namely, Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. Products include Crestor, Atacand, Selok/Toprol-XL, Zestril, Nexium, Losec/Prilosec, Entocort, Synagis, FluMist, Seroquel, Diprivan, Naropin, Xylocaine, Arimidex, Zoladex, Iressa, Faslodex, Nolvadex, Abraxane, Symbicort Turbuhaler, Pulmicort, Rhinocort and Accolate. The Group operates in the United Kingdom, Belgium, France, Germany, Italy, Spain, Sweden, the Netherlands, Canada, Puerto Rico, the Cayman Islands, the United States of America, Australia and Japan. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on AstraZeneca plc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
